Tendinitis Treatment Market

Global Tendinitis Treatment Market Size, Trends & Analysis - Forecasts to 2026 By Condition (Achilles Tendinitis, Adductor Tendinitis, Biceps Tendinitis, Elbow Tendinitis, Rotator Cuff Tendinitis, Jumpers Knee, Trigger Finger, Others), By Treatment (Diagnosis, Therapy, Surgery, Medical Devices, Others), By End-User (Hospitals & Clinics, Medical Research Centers, Academic Institutes, Others), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on November 29 2022 with the latest and most recent market numbers

Tendinitis Treatment Market Size

The global tendinitis treatment market is estimated to be valued at USD 6.46 Billion in 2021 and is projected to reach USD 9.42 Billion by 2026 at a CAGR of 7.85%. The spike in the proportion of individuals afflicted by tendinitis, particularly from sports injuries, and its preponderance among patients treated with the same are the crucial aspects driving market advancement. 

The exacerbation of chronic disorders such as arthritis and diabetes, the enhancement of novel technologies, methodologies, and therapeutic forms of treatment that assist in the medication of tendinitis, an increase in government financing, and substantial investments from large corporations in the healthcare industry are all vital aspects influencing the global tendinitis treatment market.

The rapidly evolving healthcare industry, soaring healthcare spending, the growing proportion of the aging demographic demanding preventive care, technological enhancement in therapies and prognosis, and expanding government subsidies are notable driving elements for the market. Tendonitis is a reasonably prevalent problem. The ultimate occurrence and proliferation rise as people gets older. Some are more ubiquitous, in males, such as golfer's elbow, while others, including trigger finger, are more pervasive in females. Diabetes patients are more likely to experience trigger fingers. Overuse tendinitis of the hand and wrist accounts for up to 50% of all sports injuries in the United States.

The treatment's adverse effects through the intake of pain relievers or OTC drugs, namely Nonsteroidal anti-inflammatory drugs (NSAIDs), as well as the expense of tendinitis diagnosis, are inclined to constrain the global market. However, the skyrocketing preponderance of sports injuries, on the other hand, has fueled the growth of this market.

According to the Center for Disease Control and Prevention, approximately 10% of children and adolescents who participate in sports sustain minor or major injuries. Rising consciousness of sports injuries, as well as a burgeoning accentuation on early prognosis and therapeutic interventions for sports injuries, all have an impact on the market expansion. RICE (Rest, Ice, Compression, and Elevation) is the most commonly used instantaneous treatment option. Furthermore, the provision of competent medical care specialists in the domain of sports medicine is a pertinent determinant driving the market.

Scientific transformation in the cure and management of diseases of muscle inflammation also contributes to market development. Furthermore, soaring incidents of muscular injuries as a result of sporting events, over-exercise, and tedious muscle movements drive market expansion. However, the inadequacy of understanding in underdeveloped countries, as well as the availability of unconventional treatments, may stymie the global tendinitis treatment market. To eradicate this constraint's overall impact, market rapid expansion is being driven by evolving technologies and massive investments in research and development.

global tendinitis treatment market

Tendinitis Treatment Market: By Condition

Depending on the condition, the market is categorized as Achilles tendinitis, adductor tendinitis, biceps tendinitis, elbow tendinitis, rotator cuff tendinitis, jumper's knee, trigger finger, and others. Achilles tendinitis is the most pervasive type of tendinitis, as it is the largest tendon in the body and is the most probable to be injured or damaged. This is a major driver of the global market.

Achilles tendinitis affects both competitive and recreational sportsmen, as well as non-athletes. Achilles tendon malfunction occurs at a rate of 5 to 10 per 100,000 people in the general population, but it may be significantly greater in certain areas and populaces and it is on the rise overall. Recreational sports account for more than 80% of all ruptures.

Tendinitis Treatment Market: By Treatment

Depending on the treatment, the market is categorized as diagnosis, therapy, surgery, medical devices, and others. The therapy segment contributed to a significant share of the market owing to its reduced expense, widespread accessibility, elevated effectiveness, and few or no repercussions correlated with treatment. Physical therapy includes soft tissue or joint mobilization via physiotherapy, a personalized exercise program, the use of pressure-relieving equipment, body position and walking assessment, and education programs on acceptable exercises.

The majority of tendinitis cases can be efficiently addressed with physical therapy. A program of specialized exercise intended to stretch and fortify the impacted muscle-tendon unit benefits the patient. Eccentric strengthening, for example, emphasizes muscle contraction while lengthening. This has been exhibited to be an extremely effective therapy for several chronic tendon illnesses, and it is now regarded as first-line therapy. Eccentric strengthening has been shown to be very efficacious for chronic tendon problems, and manual therapy, including certain kinds of massage, can aid in the recovery process.

Tendinitis Treatment Market: By End-User

Depending on the end-user, the market is categorized as hospitals & clinics, medical research centers, academic institutes, and others. Owing to an increase in the proportion of patient populations admitted to hospitals and clinics for diagnosis, as well as the healthcare architecture offered by hospitals, the hospitals & clinics segment held a significant share of the market.

Skilled healthcare professionals in hospitals are competent to provide treatments like FAST, or Focused Aspiration of Scar Tissue. It is the most appropriate and efficient treatment for tendinitis, with patients returning to their regular operations within one or two months. It is a minimally invasive procedure that removes the impacted tendon scar tissue with ultrasonography and some minuscule equipment.

asia pacific tendinitis treatment market

Tendinitis Treatment Market: By Region

North America has the largest share of the global market, trailed by Europe. The growing proportion of people afflicted with tendinitis, technological breakthroughs, and a sizeable multitude of government subsidies and financing for technology production drive the market in the region. The United States is the dominant country in this area owing to its established healthcare architecture and increased R&D financial support.

Europe is the second-largest market. Germany dominates in this region owing to groundbreaking product advancements and the swift incorporation of novel treatment options.

The Asia Pacific region is experiencing rapid growth in this market, owing primarily to a promptly altering healthcare sector, heightened understanding, and soaring healthcare investment.

Tendinitis Treatment Market Share and Competitor Analysis

Alkem Labs Ltd., Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Merck and Co. Inc., GlaxoSmithKline plc, Pfizer, Sandoz AG, Perrigo Company plc, Akron Inc., Almatica Pharma, Inc., Lupin Limited, Mylan N.V., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals plc, AstraZeneca, Bayer, and Teva Pharmaceutical Industries, among others, are the key players in the market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Methodology

1.1    Market Scope & Definitions

1.2    Estimates & Forecast Calculation

1.3    Historical Data Overview And Validation

1.4    Data Sources

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Tendinitis Treatment Industry Overview, 2019-2026

2.1.1    Industry Overview

2.1.2    Condition Overview

2.1.3    End-User Overview

2.1.4    Treatment Overview

2.1.5    Regional Overview

Chapter 3   Tendinitis Treatment Market Trends

3.1    Market Segmentation

3.2    Industry Background, 2019-2026

3.3    Market Key Trends

3.3.1    Positive Trends

3.3.1.1    Spike In The Proportion Of Individuals Afflicted By Tendinitis, Particularly From Sports Injuries

3.3.1.2    The Exacerbation Of Chronic Disorders

3.3.2    Industry Challenges

3.3.2.1    Inadequacy Of Understanding In Underdeveloped Countries

3.4    Prospective Growth Scenario

3.4.1    Condition Growth Scenario

3.4.2    End-User Growth Scenario

3.4.3    Treatment Growth Scenario

3.5    COVID-19 Influence over Industry Growth

3.6    Porter’s Analysis

3.7    PESTEL Analysis

3.8    Value Chain & Supply Chain Analysis

3.9    Regulatory Framework

3.9.1    North America

3.9.2    Europe

3.9.3    APAC

3.9.4    LATAM

3.9.5    MEA

3.10    Technology Overview

3.11    Market Share Analysis, 2020

3.11.1    Company Positioning Overview, 2020

Chapter 4   Tendinitis Treatment Market, By Condition

4.1    Condition Outlook

4.2    Achilles Tendinitis

4.2.1    Market Size, By Region, 2019-2026 (USD Billion)

4.3    Adductor Tendinitis

4.3.1    Market Size, By Region, 2019-2026 (USD Billion)

4.4    Biceps Tendinitis

4.4.1    Market Size, By Region, 2019-2026 (USD Billion)

4.5    Elbow Tendinitis

4.5.1    Market Size, By Region, 2019-2026 (USD Billion)

4.6    Rotator Cuff Tendinitis

4.6.1    Market Size, By Region, 2019-2026 (USD Billion)

4.7    Jumper's Knee

4.7.1    Market Size, By Region, 2019-2026 (USD Billion)

4.8    Trigger Finger

4.8.1    Market Size, By Region, 2019-2026 (USD Billion)

4.9    Others

4.9.1    Market Size, By Region, 2019-2026 (USD Billion)

Chapter 5   Tendinitis Treatment Market, By End-User

5.1    End-User Outlook

5.2    Hospitals & Clinics

5.2.1    Market Size, By Region, 2019-2026 (USD Billion)

5.3    Medical Research Centers

5.3.1    Market Size, By Region, 2019-2026 (USD Billion)

5.4    Academic Institutes

5.4.1    Market Size, By Region, 2019-2026 (USD Billion)

5.5    Others

5.5.1    Market Size, By Region, 2019-2026 (USD Billion)

Chapter 6   Tendinitis Treatment Market, By Treatment

6.1    Treatment Outlook

6.2    Diagnosis

6.2.1    Market Size, By Region, 2019-2026 (USD Billion)

6.3    Therapy

6.3.1    Market Size, By Region, 2019-2026 (USD Billion)

6.4    Surgery

6.4.1    Market Size, By Region, 2019-2026 (USD Billion)

6.5    Medical Devices

6.5.1    Market Size, By Region, 2019-2026 (USD Billion)

6.6    Others

6.6.1    Market Size, By Region, 2019-2026 (USD Billion)

Chapter 7   Global Depth Filtration Market, By Region

7.1    Regional outlook

7.2    North America

7.2.1    Market Size, By Country 2019-2026 (USD Billion)

7.2.2    Market Size, By Condition, 2019-2026 (USD Billion)

7.2.3    Market Size, By End-User, 2019-2026 (USD Billion)

7.2.4    Market Size, By Treatment, 2019-2026 (USD Billion)

7.2.5    U.S.

7.2.5.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.2.5.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.2.5.3   Market Size, By Treatment, 2019-2026 (USD Billion)

7.2.6    Canada

7.2.6.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.2.6.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.2.6.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.3    Europe

7.3.1    Market Size, By Country 2019-2026 (USD Billion)

7.3.2    Market Size, By Condition, 2019-2026 (USD Billion)

7.3.3    Market Size, By End-User 2019-2026 (USD Billion)

7.3.4    Market Size, By Treatment, 2019-2026 (USD Billion)

7.3.5    Germany

7.3.5.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.3.5.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.3.5.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.3.6    UK

7.3.6.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.3.6.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.3.6.3     Market Size, By Treatment, 2019-2026 (USD Billion)

7.3.7   France

7.3.7.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.3.7.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.3.7.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.3.8    Italy

7.3.8.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.3.8.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.3.8.3     Market Size, By Treatment, 2019-2026 (USD Billion)

7.3.9    Spain

7.3.9.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.3.9.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.3.9.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.3.10   Russia

7.3.10.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.3.10.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.3.10.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.4    Asia Pacific

7.4.1    Market Size, By Country,2019-2026 (USD Billion)

7.4.2    Market Size, By Condition, 2019-2026 (USD Billion)

7.4.3    Market Size, By End-User, 2019-2026 (USD Billion)

7.4.4    Market Size, By Treatment, 2019-2026 (USD Billion)

7.4.5    China

7.4.5.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.4.5.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.4.5.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.4.6    India

7.4.6.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.4.6.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.4.6.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.4.7    Japan

7.4.7.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.4.7.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.4.7.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.4.8    Australia

7.4.8.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.4.8.2    Market size, By End-User, 2019-2026 (USD Billion)

7.4.8.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.4.9    South Korea

7.4.9.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.4.9.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.4.9.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.6.5    Latin America

7.5.1    Market Size, By Country 2019-2026 (USD Billion)

7.5.2    Market Size, By Condition, 2019-2026 (USD Billion)

7.5.3    Market Size, By End-User, 2019-2026 (USD Billion)

7.5.4    Market Size, By Treatment, 2019-2026 (USD Billion)

7.5.5    Brazil

7.5.5.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.5.5.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.5.5.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.5.6    Mexico

7.5.6.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.5.6.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.5.6.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.5.7   Argentina

7.5.7.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.5.7.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.5.7.3     Market Size, By Treatment, 2019-2026 (USD Billion)

7.6    MEA

7.6.1    Market Size, By Country 2019-2026 (USD Billion)

7.6.2    Market Size, By Condition, 2019-2026 (USD Billion)

7.6.3    Market Size, By End-User, 2019-2026 (USD Billion)

7.6.4    Market Size, By Treatment, 2019-2026 (USD Billion)

7.6.5    Saudi Arabia

7.6.5.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.6.5.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.6.5.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.6.6    UAE

7.6.6.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.6.6.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.6.6.3    Market Size, By Treatment, 2019-2026 (USD Billion)

7.6.7    South Africa

7.6.7.1    Market Size, By Condition, 2019-2026 (USD Billion)

7.6.7.2    Market Size, By End-User, 2019-2026 (USD Billion)

7.6.7.3    Market Size, By Treatment, 2019-2026 (USD Billion)

Chapter 8   Company Landscape

8.1    Competitive Analysis, 2020

8.2    Alkem Labs Ltd.

8.2.1    Company Overview

8.2.2    Financial Analysis

8.2.3    Strategic Positioning

8.2.4    Info Graphic Analysis

8.3    Abbott

8.3.1    Company Overview

8.3.2    Financial Analysis

8.3.3    Strategic Positioning

8.3.4    Info Graphic Analysis

8.4    Boehringer Ingelheim Pharmaceuticals, Inc.

8.4.1    Company Overview

8.4.2    Financial Analysis

8.4.3    Strategic Positioning

8.4.4    Info Graphic Analysis

8.5    Merck and Co. Inc.

8.5.1    Company Overview

8.5.2    Financial Analysis

8.5.3    Strategic Positioning

          8.5.4    Info Graphic Analysis

8.6    GlaxoSmithKline plc

8.6.1    Company Overview

8.6.2    Financial Analysis

8.6.3    Strategic Positioning

8.6.4    Info Graphic Analysis

8.7    Pfizer

8.7.1    Company Overview

8.7.2    Financial Analysis

8.7.3    Strategic Positioning

8.7.4    Info Graphic Analysis

8.8    Sandoz AG

8.8.1    Company Overview

8.8.2    Financial Analysis

8.8.3    Strategic Positioning

8.8.4    Info Graphic Analysis

8.9    Perrigo Company plc

8.9.1    Company Overview

8.9.2    Financial Analysis

8.9.3    Strategic Positioning

8.9.4    Info Graphic Analysis

8.10   Akron Inc.

8.10.1    Company Overview

8.10.2    Financial Analysis

8.10.3    Strategic Positioning

8.10.4    Info Graphic Analysis

8.11   Almatica Pharma, Inc.

8.11.1    Company Overview

8.11.2    Financial Analysis

8.11.3    Strategic Positioning

8.11.4    Info Graphic Analysis

8.12   Lupin Limited

8.12.1    Company Overview

8.12.2    Financial Analysis

8.12.3    Strategic Positioning

8.12.4    Info Graphic Analysis

8.13   Mylan N.V.

8.13.1    Company Overview

8.13.2    Financial Analysis

8.13.3    Strategic Positioning

8.13.4    Info Graphic Analysis

8.14   Sun Pharmaceutical Industries Ltd.

8.14.1    Company Overview

8.14.2    Financial Analysis

8.14.3    Strategic Positioning

8.14.4    Info Graphic Analysis

8.15   Hikma Pharmaceuticals plc

8.15.1    Company Overview

8.15.2    Financial Analysis

8.15.3    Strategic Positioning

8.15.4    Info Graphic Analysis

8.16   AstraZeneca

8.16.1    Company Overview

8.16.2    Financial Analysis

8.16.3    Strategic Positioning

8.16.4    Info Graphic Analysis

8.17   Bayer

8.17.1    Company Overview

8.17.2    Financial Analysis

8.17.3    Strategic Positioning

8.17.4    Info Graphic Analysis

8.18   Teva Pharmaceutical Industries

8.18.1    Company Overview

8.18.2    Financial Analysis

8.18.3    Strategic Positioning

8.18.4    Info Graphic Analysis

8.19   Other Companies

8.19.1    Company Overview

8.19.2    Financial Analysis

8.19.3    Strategic Positioning

8.19.4    Info Graphic Analysis

The Global Tendinitis Treatment Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Tendinitis Treatment Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy

Frequently Asked Questions

The global tendinitis treatment market size is projected to grow from USD 6.46 billion in 2021 to USD 9.42 billion by 2026, at a CAGR of 7.85% during the forecast period.
Key and innovative vendors in the tendinitis treatment market include Alkem Labs Ltd., Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Merck and Co. Inc., GlaxoSmithKline plc, Pfizer, Sandoz AG, Perrigo Company plc, Akron Inc., Almatica Pharma, Inc., Lupin Limited, Mylan N.V., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals plc, AstraZeneca, Bayer, and Teva Pharmaceutical Industries, among others, are the key players in the market.
North America is estimated to hold the highest market share in the tendinitis treatment market.
Globally, Covid-19 impact on the future tendinitis treatment market will be quite significant for the manufacturers. North America would be leading because of the growing proportion of people afflicted with tendinitis. Subsequently, the Asia Pacific region is expected to grow the fastest because of the soaring level of healthcare investment.
The major driving factors for the tendinitis treatment market include the steadily increasing proportion of individuals afflicted by tendinitis, particularly from sports injuries; the exacerbation of chronic disorders such as arthritis and diabetes; the enhancement of novel technologies, methodologies, and therapeutic forms of treatment that assist in the medication of tendinitis; an increase in government financing; substantial investments from large corporations in the healthcare industry.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius